David Recker
Chief Tech/Sci/R&D Officer at BULLFROG AI HOLDINGS, INC.
David Recker active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BULLFROG AI HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | - | - |
| Jjk Consulting, Inc. | Corporate Officer/Principal | - | - |
Career history of David Recker
Former positions of David Recker
| Companies | Position | Start | End |
|---|---|---|---|
| Takeda Global Research & Development Center, Inc. | Corporate Officer/Principal | 2001-12-31 | 2011-12-31 |
| PALISADE BIO, INC. | Chief Tech/Sci/R&D Officer | 2017-11-07 | 2021-04-26 |
| VERICEL CORPORATION | Chief Tech/Sci/R&D Officer | 2014-03-31 | - |
Training of David Recker
| University of Michigan Medical School | Doctorate Degree |
Statistics
International
| United States | 7 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| VERICEL CORPORATION | Health Technology |
| BULLFROG AI HOLDINGS, INC. | Technology Services |
| Private companies | 3 |
|---|---|
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD. | Health Technology |
| Takeda Global Research & Development Center, Inc. | |
| Jjk Consulting, Inc. |
- Stock Market
- Insiders
- David Recker
- Experience
